Adicet Bio, Inc. (ACET)
NASDAQ: ACET · IEX Real-Time Price · USD
1.435
-0.085 (-5.59%)
May 2, 2024, 3:02 PM EDT - Market open
Adicet Bio Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
143
Market Cap
118.74M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 0 | - | - |
| Dec 31, 2022 | 24.99M | 15.26M | 156.83% |
| Dec 31, 2021 | 9.73M | -8.17M | -45.65% |
| Dec 31, 2020 | 17.90M | 16.91M | 1,699.30% |
| Dec 31, 2019 | 995.00K | -7.19M | -87.84% |
| Dec 31, 2018 | 8.18M | - | - |
| Dec 31, 2017 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Amylyx Pharmaceuticals | 380.79M |
| So-Young International | 211.29M |
| Outset Medical | 130.38M |
| Repare Therapeutics | 51.13M |
| Biodesix | 49.09M |
| Augmedix | 44.86M |
| Zomedica | 25.19M |
| DBV Technologies | 15.73M |
ACET News
- 1 day ago - Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 9 days ago - Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting - Business Wire
- 24 days ago - Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference - Business Wire
- 6 weeks ago - Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress - Business Wire
- 7 weeks ago - Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference - Business Wire
- 3 months ago - Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference - Business Wire
- 3 months ago - Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares - Business Wire
- 3 months ago - Adicet Bio, Inc. Announces Pricing of Public Offering - Business Wire